Nature Reviews Nephrology

Article	Citations
A UMOD variant with intermediate effects	785
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	589
Making advance care planning easier for adults with kidney disease and their clinicians	442
Mentorship in the lives of scholars	435
Engineered CAR macrophages target kidney inflammation	382
Role of the gut microbiota in the pathogenesis of IgA nephropathy	379
Endoplasmic reticulum-mediated organelle crosstalk in kidney disease	376
Inhibitory effects of oestradiol on ferroptosis may underlie sex differences in AKI	336
The changing landscape of kidney health and disease in Africa	283
Vaccination in patients with kidney failure: lessons from COVID-19	278
Uropathogen and host responses in pyelonephritis	259
The GLP-1 receptor agonist revolution comes to nephrology	217
Treatment of chronic kidney disease in older populations	213
Disaster preparedness for patients with kidney disease	202
Kidney health within the broader non-communicable disease agenda	190
Urine as a source of biomarkers and biological knowledge in chronic kidney disease	186
Designing acute kidney injury clinical trials	175
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	172
Daprodustat for anaemia in CKD	162
A single-cell atlas of DKD treatment responses	162
Genetic determinants of urine and plasma metabolite levels	159
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	156
Beyond state borders: transforming dialysis care for undocumented immigrants	155
Consideration of sex differences is necessary to achieve health equity	148
Roles of sensory receptors in non-sensory organs: the kidney and beyond	145

Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	141
Complosome — the intracellular complement system	138
Strategic rebalancing of kidney-related investments is key to implementing the WHO kidney health resolution	138
Phosphate sensing via PTC glycolysis	137
Increasing diversity and inclusion in nephrology clinical trials	134
Mutational signatures of ccRCC vary between geographical regions	132
Bringing Pride to nephrology	125
20 years of Nature Reviews Nephrology	122
Informing clinical decision making during a pandemic — a call for better preparedness	117
Reducing preventable acute kidney injury in a hospital setting	110
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	110
Clonal haematopoiesis and AKI	109
The effects of sex hormone therapy on kidney function	109
Menopause and chronic kidney disease	107
Interferon blockade in lupus: effects on antiviral immunity	101
Aquaporin water channels: roles beyond renal water handling	94
The roles of hyaluronan in kidney development, physiology and disease	91
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	88
From mapping kidney function to mechanism and prediction	87
Tertiary lymphoid organs contribute to kidney allograft rejection	86
Identification of erythropoietin-producing cells	86
Design of a renal-sparing antifungal	82
NUAK1 promotes kidney fibrosis	80
Heat and health inequity: acting on determinants of health to promote heat justice	79
Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure	77
Treatment of SLE with anti-CD19 CAR-T cells	77
Benefits of actin cytoskeleton stabilization	73
Pathological mechanisms of kidney disease in ageing	70
Salt substitution: opportunities and challenges for nephrology	70
Long-term health outcomes associated with hydration status	68
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	65
From fat to filter: the effect of adipose tissue-derived signals on kidney function	65
Neutrophils and NETs in kidney disease	65
RNA-binding proteins and their role in kidney disease	64
The role of complement in kidney disease	64
Reaping the rewards of mechanistic discovery in glomerular disease	63
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	62
The evolving landscape of immune-mediated glomerular diseases	61
Network medicine: an approach to complex kidney disease phenotypes	60
Combination therapy for kidney disease in people with diabetes mellitus	58
A pathway of osmotic stress-induced necroptosis	57
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	56
An integrated approach towards a public health perspective on chronic kidney disease	55
MSC therapy for diabetic kidney disease and nephrotic syndrome	55
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	54
A golden year of innovative kidney disease therapeutics	54
Consequence of microvascular inflammation in transplantation	53
Ketogenic diet benefits in critically ill patients with sepsis	53
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	53
CKD-specific ASCVD risk prediction tools	53

The cilia mechanosensation debate gets (bio)physical	52
Consequences of famine and malnourishment on kidney health	51
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	51
Long COVID and the kidney	51
Transcatheter mitral valve repair in patients with CKD	49
PDGFRβ CAR T cells improve fibrosis in kidney disease models	49
Immunological features of clear-cell renal-cell carcinoma and resistance to immune checkpoint inhibitors	49
Continuing kidney care in conflicts	48
Educating primary healthcare providers about kidney disease	47
Kidney complications of parasitic diseases	46
Role of the cGAS–STING pathway in systemic and organ-specific diseases	45
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	45
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	44
Dietary protection of proximal tubules in diabetes	43
Mechanism of B cell survival in lupus nephritis	42
Gene therapy in a model of nephrotic syndrome	40
Targeting IL-1Ra to attenuate fungal infection	39
Multifaceted innovations needed to advance transplant nephrology	37
Mannose as a driver of γδ T cell kidney infiltration	36
Steps forward in the treatment of IgA nephropathy	36
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	35
IL-6 signalling contributes to the pathogenesis of uraemic calciphylaxis	35
The kidney is a novel target of metformin	35
Epithelial cell states associated with kidney and allograft injury	34
Born too soon: lifelong kidney risks and the importance of early intervention	33
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	32
Chronic cardiovascular–kidney disorder: a new conceptual framework	30
A guide to gene–disease relationships in nephrology	30
Generation of self-assembling kidney progenitor assembloids	30
Role of necroptosis in kidney health and disease	30
Metabolic alterations in hereditary and sporadic renal cell carcinoma	30
Fasting induces structural and functional changes in the peritoneal membrane	29
Derivation of collecting duct organoids	29
A multidisciplinary approach to cardiorespiratory fitness in CKD	29
Author Correction: Therapeutic advances in COVID-19	29
ALCAM–CD6 in lupus nephritis	28
Leveraging data as a patient–scientist: frustrations and opportunities	28
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	28
Strategies to achieve gender equity in nephrology	28
Renal nerves in physiology, pathophysiology and interoception	27
The increasing burden of mild and moderate anaemia in CKD	27
Green nephrology: from evidence to action	27
The immunology of sepsis: translating new insights into clinical practice	24
Tissue-resident memory T cells in the urogenital tract	23
From big data to smart decisions: artificial intelligence in kidney risk assessment	23
Insights into the impact of pregnancy on kidney disease	22
The impact of intrauterine growth restriction and prematurity on nephron endowment	21
A guide to uraemic toxicity	21
Acute kidney injury in patients with burns	21
The perils of misinformation: when health literacy goes awry	21
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	20
Fibroblast activation and heterogeneity in fibrotic disease	20
Switching off SOX9 for epithelial recovery after AKI	20
CD38 — a new target in renal immune disease	19
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	19
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	18
Hope for resistant hypertension through BrigHTN and PRECISION	18
Digital determinants of health: opportunities and risks amidst health inequities	18
Collagen formation, function and role in kidney disease	17
Impact of persistent conflict and destabilizing events on dialysis care	17
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	17
The genetics of kidney stone disease and nephrocalcinosis	17
Crosstalk between glomeruli and tubules	17
The impact of population ageing on the burden of chronic kidney disease	16
Nephrology and women’s health post-Roe v. Wade: we must do better	16
Chlorthalidone in advanced CKD	16
Podocyte-targeted therapies — progress and future directions	15
Bridging the gap of referral to nephrology care	15
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	15
Deep learning applications in digital pathology	14
Role of perivascular cells in kidney homeostasis, inflammation, repair and fibrosis	14
Application of spatial-omics to the classification of kidney biopsy samples in transplantation	14
Anti-tumour antibody-producing plasma cells disseminate from tertiary lymphoid structures	13
Cellular senescence: the good, the bad and the unknown	13
Use of kidneys from SARS-CoV-2 infected donors	13
Pathogenic cellular and molecular mediators in lupus nephritis	13
P3H2 in glomerular basement membrane regulation	12
Belzutifan: a novel therapy for von Hippel–Lindau disease	12
mTORC1 under the control of CB1R	12
Publisher Correction: Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	12

Increased PD1 signalling in kidney ageing	12
Lived experience and empathy: lessons learned as a nephrologist with kidney disease	12
The evolving story of apolipoprotein L1 nephropathy: the end of the beginning	11
Progress towards solving the donor organ shortage	11
Advances and challenges in kidney fibrosis therapeutics	11
Trained immunity: from kidney failure to organ transplantation	11
Insights into glomerular function and disease pathogenesis	11
New evidence of the impact of mitochondria on kidney health and disease	10
Gasdermins and pyroptosis in the kidney	10
Pharmacogenomics in the clinic	10
New and emerging therapies for diabetic kidney disease	10
TRPM channels in health and disease	10
Incorporating dementia screening in the care of patients with kidney disease	10
Vascular damage in systemic lupus erythematosus	10
Important roles of mechanical force and hydraulic pressure in kidney function	10
Author Correction: Beyond state borders: transforming dialysis care for undocumented immigrants	10
Anti-nephrin autoantibodies: a paradigm shift in podocytopathies	9
The impact of the Russian–Ukrainian war for people with chronic diseases	9
Clonal haematopoiesis, ageing and kidney disease	9
Thiazides in kidney transplant recipients: skin in the game	9
Diuretics in patients with chronic kidney disease	9
SGLT2 inhibitors may prevent diabetes	9
Kidney health outcomes of hypertensive disorders of pregnancy	9
Inflammation and gut dysbiosis as drivers of CKD–MBD	8
Cystatin C and the misdiagnosis of CKD in older adults	8
ECM remodelling by ADAMTS12 in fibrosis	8
Disasters and kidney care: pitfalls and solutions	8
Advancing gender equity to improve kidney care for women: a patient perspective	8
The genetics and pathogenesis of CAKUT	8
Cell and gene therapy for kidney disease	8
Progress in xenotransplantation: overcoming immune barriers	8
Gut microbiome studies in CKD: opportunities, pitfalls and therapeutic potential	8
Managing climate change risks is imperative for human health	8
Electronic patient-reported outcomes in chronic kidney disease	8
Patient involvement in nephrology research	8
Advances in CRISPR therapeutics	8
The role of lysosomes in metabolic and autoimmune diseases	7
Epidemiology of haemodialysis outcomes	7
Youth-onset type 2 diabetes mellitus: an urgent challenge	7
Chronic kidney disease and the global public health agenda: an international consensus	7
Kidney and heart failure outcomes associated with SGLT2 inhibitor use	7
VISTA dampens T cell activation in injured kidney	6
Remodelling by macula densa cells	6
Intersectionality as a lens for achieving kidney health justice	6
Synchronization in the renal microcirculation	6
Avenciguat reduces albuminuria in patients with chronic kidney disease	6
Circulating osteopontin mediates acute kidney injury-induced respiratory failure	6
Including sexual orientation and gender identity data to advance nephrology care	6
New insights into kidney crosstalk with distant organs	5
A guide to studying 3D genome structure and dynamics in the kidney	5
Drug repurposing for glomerular diseases: an underutilized resource	5
Renoprotective effects of sparsentan: clinical trial evidence in IgA nephropathy and FSGS	5
The catastrophic costs of chronic kidney disease	5
The intelligent podocyte: sensing and responding to a complex microenvironment	5
Long-term lessons from EMPA-KIDNEY	5
The pathogenesis of pre-eclampsia in kidney donors	5
Paths to organ damage and risk factors in AKI	5
Post-translational modifications in kidney diseases and associated cardiovascular risk	5
Removal of small, asymptomatic kidney stones	4
Diagnosis of cardiovascular disease in patients with chronic kidney disease	4
Sexual orientation and gender identity in organ and tissue donation and transplantation	4
Improving nephrology care for people with cognitive impairments and their caregivers	4
A polygenic score predicts CKD across ancestries	4
Amino acid metabolism in kidney health and disease	4
Sex differences in kidney metabolism and DKD	4
Targeting iron uptake to correct T cell dysfunction	4
Ensuring health equity for sexual and/or gender minority individuals	4
The slit diaphragm has a conserved fishnet architecture	4
Inequities in kidney health and kidney care	4
UTX regulates accumulation of lipids via kidney serine	4
A new pathway links iron sensing with histone demethylation and regulation of mTORC1 activity	4
Iron deficiency of kidney macrophages in CKD	4
The importance of sex and gender in basic and clinical research	3
Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants	3
Improving outcomes in glomerular disease	3
Leveraging lysine metabolism for renoprotection	3
The roles of tertiary lymphoid structures in chronic diseases	3
Macrophages clean out the tubules	3
Reply to ‘Use of convalescent plasma in the treatment of COVID-19’	3
Insights into basement membrane complexity	3
Harnessing plant thylakoids to restore cellular function in AKI	3
The pathogenesis of IgA nephropathy and implications for treatment	3
Spatial transcriptomics in health and disease	3
Benefits of CoQ10 supplementation in patients with SRNS due to primary CoQ10 deficiency	3
The kidney stroma in development and disease	3
Propagation of acute kidney injury	3
Artificial intelligence approaches to enable early detection of CKD	3
Long COVID: long-term health outcomes and implications for policy and research	3
A CAAR NK cell approach to eliminate pathogenic autoantibody-secreting cells	3
Drivers and mechanisms of cognitive decline in chronic kidney disease	3
AngII autoantibodies after SARS-CoV-2 infection	3
Association of metabolic dysfunction-associated fatty liver disease with kidney disease	3
NCKs are essential to podocyte–GBM interactions	3
Supporting sexual and gender minority health-care workers	3
Managing RAAS inhibitor use in advanced CKD	3